Pursuant to Regulation 34 of SEBI (LODR) Regulations, 2015, Laurus Labs has informed that it enclosed the Notice convening the 18th Annual General Meeting (AGM) of shareholders and the Annual Report for the financial year 2022-23 which will be circulated to the shareholders through electronic mode for the AGM to be held on Friday, July 14, 2023 at 03.00 pm (IST) through video conference (VC). The Notice and the annual report will also be made available on the Company’s website at www.lauruslabs.com. The Schedule of events are enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1279.70 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2245.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: